Cannabis stocks post record weekly gains on rescheduling hopes
Source: SeekingAlpha
2025-12-13 13:22:55 ET
More on AdvisorShares Pure US Cannabis ETF, Tilray, etc.
- President Trump May Reschedule Cannabis: Should You Buy MSOS Or NewLake Capital?
- MSOS: Focused Exposure To U.S. Cannabis Stocks
- Tilray Brands Is No Longer A Strong Sell
- Trump’s Executive Order on cannabis rescheduling expected on Monday: CNBC
- Pot stocks rise on Trump's push to reclassify marijuana
Read the full article on Seeking Alpha
For further details see:
Cannabis stocks post record weekly gains on rescheduling hopes
AdvisorShares Pure US Cannabis ETF
NASDAQ: MSOS
MSOS Trading
-1.6% G/L:
$4.915 Last:
1,545,529 Volume:
$5.03 Open:
MSOS Latest News
April 24, 2026 11:41:23 am
Trump Just Eased Federal Marijuana Laws. Is there an Investment Case for Cannabis ETFs Right Now?
April 23, 2026 09:24:00 am
AdvisorShares Issues Statement on Finalization of Federal Cannabis Rescheduling
February 23, 2026 12:29:41 pm
Quantum Computing Inc. Positions Itself Between Quantum Hardware and Enterprise Adoption as Anson Funds Exits
February 17, 2026 08:15:00 pm
If Pot Stocks Rebound in 2026, These Are the 3 Best Cannabis Companies to Own
